NCT00088530 2020-02-05BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CTI BioPharmaPhase 3 Completed140 enrolled 15 charts
NCT00060684 2015-01-19Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCTI BioPharmaPhase 1 Completed30 enrolled